Kafa a 2009, JYMed ne a Pharmaceutical sha'anin a kasar Sin cewa integrates R & D, masana'antu, kasuwanci, da al'ada ci gaba da kuma masana'antu na peptide kayayyakin. Kamfanin yana da kusan ma'aikata 570, tare da ƙungiyar gudanarwa ta asali wanda ya ƙunshi ƙwararrun ƙwararrun magunguna da fiye da shekaru 20 na gogewa a cikin masana'antar peptide. JYMed yana aiki da cibiyar bincike guda ɗaya da manyan wuraren samarwa guda biyu, yana samun damar samar da sikelin da yawa a cikin peptides, yana sanya shi a matsayin jagoran masana'antu.
JYMED
samfurori
APIs na Peptide
APIs na Peptide
JYMed yana ba da fayil iri-iri na peptide APIs, gami da sama da nau'ikan 20 kamar Semaglutide, Tirzepatide, Liraglutide, Degarelix, da Oxytocin. Daga cikin waɗannan, samfurori guda biyar, ciki har da Semaglutide da Tirzepatide, sun sami nasarar kammala rajista na FDA Drug Master File (DMF).
Peptide na kwaskwarima
Peptide na kwaskwarima
JYMed yana ba da peptides na kwaskwarima masu inganci, albarkatun ƙasa, da sabis na ƙirƙira OEM daga darajar bincike zuwa darajar cGMP, duk tare da ingantaccen iko mai inganci. Our roba peptides, sananne ga su aminci da sauƙi na gyare-gyare, su ne muhimman sinadaran a cikin kwaskwarima masana'antu, isar da tabbatattun amfani ga gashi kula, rauni warkar, anti-tsufa, anti-alama, whitening, da gashin ido girma.
Sabis na CRO&CDMO
Sabis na CRO&CDMO
JYMed yana da ingantaccen tsarin masana'antar peptide mai inganci, yana ba abokan ciniki cikakken sabis na peptide da samfuran analog na peptide, gami da bincike da samar da peptides na warkewa, peptides na dabbobi, peptides na kwaskwarima, da RNA, tare da tallafi don rajista da bin ka'ida. .
Peptide na al'ada
Peptide na al'ada
A matsayin abokin ciniki-daidaitacce sha'anin, JYMed yana da wani m peptide masana'antu tsarin, tare da fiye da 20 shekaru gwaninta a peptide R&D da kuma na-da-art wurare. Muna ba da cikakken kewayon high quality peptides dangane da abokin ciniki ta bukatar: Yawan daga MG zuwa kg, da tsarki daga danye zuwa> 99%, daga wadanda ba GMP zuwa GMP sa, daga sauki peptides zuwa modified peptides, antigenic peptides ci gaba, akwai yarjejeniyar sirri.
GAME DA
JYMED
Gabatarwar JYMed, mai kera peptide na Amurka FDA ta bincika. Abubuwan da aka nuna: peptide cosemtic, peptide APIs, peptides na al'ada, irin su, Semaglutide, Liraglutide, Tirzepatide, Oxytocin, GHK, GHK-CU, Acetyl Hexapeptide-8, da sauransu Don ƙarin sani, tuntuɓi
Email: jymed@jymedtech.com
-
Tabbacin inganci
Tabbacin inganci
Duba cikakkun bayanai -
Taimakon Al'amuran Mulki
Taimakon Al'amuran Mulki
Duba cikakkun bayanai -
Fa'idodi a cikin R&D da Kasuwanci
Fa'idodi a cikin R&D da Kasuwanci
Duba cikakkun bayanai -
Halayen haƙƙin mallaka
Halayen haƙƙin mallaka
Duba cikakkun bayanai -
Takaddun cancanta
Takaddun cancanta
Duba cikakkun bayanai
labarai da bayanai
Labarai masu kayatarwa | Mafi Girman Kayan Samar da Semaglutide API na China Ya Wuce Binciken FDA na Amurka
Daga 26 ga Agusta zuwa 30 ga Agusta, 2024, wurin samar da peptide na JYMed, Hubei JX Bio-Pharmaceutical Co., Ltd., ya yi nasarar shawo kan wani binciken da Hukumar Abinci da Magunguna ta Amurka (FDA) ta gudanar. Binciken ya kunshi muhimman wurare...
2024 CPHI Milan Pharmaceutical Nunin Recap
01. Baje kolin Baje kolin A ranar 8 ga Oktoba, 2024 CPHI Worldwide Pharmaceutical Exhibition ya fara a Milan. A matsayin daya daga cikin muhimman abubuwan da suka faru na shekara-shekara a masana'antar harhada magunguna ta duniya, ya jawo mahalarta daga kasashe da yankuna 166. Da over...
Labarai masu kayatarwa | JYMed's Liraglutide API yana karɓar Takaddun shaida na WC
A ranar 12 ga Oktoba, 2024, JYMed's Liraglutide API ya sami takaddun Tabbacin Rubuce-rubuce (WC), wanda ke nuna muhimmin mataki ga nasarar fitar da API zuwa kasuwar EU. WC (Tabbacin Rubuce-rubuce)...
